RBC Bearings (RBC) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
30 Jun, 2026Executive summary
Net sales for Q1 FY2025 reached $406.3 million, up 5.0% year-over-year, driven by 23.7% growth in Aerospace/Defense and a 3.5% decline in Industrial.
Net income attributable to common stockholders rose 25.7% to $55.7 million, with diluted EPS up to $1.90 from $1.52 year-over-year.
Adjusted EBITDA margin increased to a record 33.0%, up from 31.1% last year.
Gross margin improved to 45.3% from 43.4% year-over-year, reflecting manufacturing efficiencies and favorable product mix.
Backlog increased to $825.8 million as of June 29, 2024, up from $821.5 million at March 30, 2024.
Financial highlights
Operating income was $97.5 million, up 14.7% year-over-year; adjusted operating income was $97.5 million vs $85.3 million.
Adjusted net income attributable to common stockholders was $74.5 million, up from $62.0 million.
Diluted EPS was $1.90, up from $1.52; adjusted diluted EPS was $2.54, up from $2.13.
Interest expense declined 16% year-over-year to $17.2 million due to ongoing debt repayment and interest rate swap benefits.
Free cash flow for the quarter was $88.4 million, with a conversion rate of 144.0%.
Outlook and guidance
Q2 FY2025 net sales expected between $395.0 million and $405.0 million, representing 2.4% to 5.0% growth year-over-year.
Gross margin guidance for Q2 and Q3 is down 100–200 basis points sequentially due to fewer production days and less favorable mix; Q2 guidance is 43.0% to 44.0%.
SG&A as a percentage of sales expected to rise in Q2 and Q3 before normalizing in Q4; Q2 guidance is 17.25% to 17.75%.
Aerospace and defense expected to maintain strong performance through year-end, with some seasonal fluctuations and strong backlog supporting future sales.
Industrial markets anticipated to strengthen in the second half, with recovery in semiconductor and oil & gas sectors.
Latest events from RBC Bearings
- Precision bearings leader posts $1.87B sales, $18B market cap, and 3,838% TSR since IPO.RBC
Investor presentation31 May 2026 - Q4 sales up 18.3% year-over-year, with record backlog and strong outlook for FY2027.RBC
Q4 202620 May 2026 - Q3 sales up 17% with strong Aerospace/Defense and VACCO gains; Q4 outlook remains robust.RBC
Q3 20265 Feb 2026 - Q2 net sales up 3.2% to $397.9M, driven by 12.5% Aerospace/Defense growth.RBC
Q2 202517 Jan 2026 - Q3 net sales up 5.5%, adjusted EPS up 26.5%, and Q4 outlook remains strong.RBC
Q3 20259 Jan 2026 - Record-setting growth, strong governance, and shareholder-aligned executive pay define this proxy.RBC
Proxy Filing1 Dec 2025 - Record growth, strong governance, and key votes on directors, auditor, and executive pay.RBC
Proxy Filing1 Dec 2025 - Record-breaking financials, governance updates, and key shareholder votes define this year's meeting.RBC
Proxy Filing1 Dec 2025 - Record financials, enhanced executive pay practices, and key governance votes mark this year's proxy.RBC
Proxy Filing1 Dec 2025